Risk Minimisation Material: Myalepta (metreleptin) Healthcare Professional Guide

This highlights the main areas of risk with metreleptin treatment; hypoglycaemia with concomitant use of insulin and other anti-diabetics, acute pancreatitis with abrupt discontinuation, unplanned pregnancy due to improvement of hormonal dysfunction, and medication errors.

SPS commentary:

A patient care guide, a patient dose information card, and a specialist prescriber guide have been produced in conjunction




electronic Medicines compendium

Resource links:

Patient care guide

Patient dose information card

Specialist Prescriber guide